Skip to main content
PLOS One logoLink to PLOS One
. 2024 Apr 2;19(4):e0301572. doi: 10.1371/journal.pone.0301572

Retraction: SATB1 Overexpression Regulates the Development and Progression in Bladder Cancer through EMT

The PLOS ONE Editors
PMCID: PMC10986978  PMID: 38564501

This article [1] was identified as one of a group of articles connected by concerns about image reuse [213].

The image concerns in this article [1] affect Figs 3 and 6. Specifically,

  • In Fig 3, the following western blot results appear similar:
    • ○ Fig 3B ZEB2 panel lanes 2–3 and Fig 3B GAPDH panel lanes 1–2 when stretched across the horizontal and vertical axes.
    • ○ Fig 3D Snail and Fig 3D Vimentin panels.
  • The following panels appear to partially overlap:
    • ○ Fig 6A BIU-87 Migration of [1] and Fig 2A MDA-MB-231 miR-181b+CCL18 of [2].
    • ○ Fig 6A Control vector Migration of [1] and Fig 2B MCF-7 miR-181b+CCL18 of [2].
    • ○ Fig 6A pcDNA3.1-SATB1 Migration of [1] and Fig 2B MCF-7 CCL18 of [2].
    • ○ Fig 6A BIU-87 Invasion of [1] and Fig 2A MCF-7 miR-181b+CCL18 of [2].
    • ○ Fig 6A Control vector Invasion of [1] and Fig 2A MDA-MB-231 CCL18 of [2].
    • ○ Fig 6A pcDNA3.1-SATB1 Invasion of [1], Fig 2A MCF-7 CCL18 of [2], Fig 2B MDA-MB-231 CCL18 of [2], and Fig 2B MDA-MB-231 miR-181b+CCL18 of [2].
    • ○ Fig 6B T24 Invasion of [1], Fig 4A Migration Control Vector of [34], and Fig 3D Eca-109/pCMV-SOX2-Ctr siRNA of [5].

The authors did not comment on the above concerns.

The PLOS ONE Editors retract this article [1] due to the above image concerns that call into question the reliability of the reported results.

FW agreed with the retraction. CC, ZW, XX, HZ, SX, XC, JW, SL, YZ, WX, ZZ, CJ, and ZZ either did not respond directly or could not be reached.

References

  • 1.Wan F, Cheng C, Wang Z, Xiao X, Zeng H, Xing S, et al. (2015) SATB1 Overexpression Regulates the Development and Progression in Bladder Cancer through EMT. PLoS ONE 10(2): e0117518. 10.1371/journal.pone.0117518 [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
  • 2.Wang L, Wang YX, Chen LP, Ji ML (2016) Upregulation of microRNA-181b inhibits CCL18-induced breast cancer cell metastasis and invasion via the NF-κB signaling pathway. Oncology Letters 12(6): 4411–4418. 10.3892/ol.2016.5230 [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
  • 3.Cheng C, Wan F, Liu L, Zeng F, Xing S, Wu X, et al. (2014) Overexpression of SATB1 Is Associated with Biologic Behavior in Human Renal Cell Carcinoma. PLoS ONE 9(5): e97406. 10.1371/journal.pone.0097406 [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
  • 4.The PLOS ONE Editors (2024) Retraction: Overexpression of SATB1 Is Associated with Biologic Behavior in Human Renal Cell Carcinoma. PLoS ONE 19(4): e0301571. 10.1371/journal.pone.0301571 [DOI] [PubMed] [Google Scholar]
  • 5.Gao H, Teng C, Huang W, Peng J, Wang C (2015) SOX2 Promotes the Epithelial to Mesenchymal Transition of Esophageal Squamous Cells by Modulating Slug Expression through the Activation of STAT3/HIF-α Signaling. International Journal of Molecular Sciences 16(9): 21643–21657. 10.3390/ijms160921643 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Jiang LT, Wan CH, Guo QH, Yang SJ, Wu JD, Cai J (2018) Long Noncoding RNA Metastasis-Associated Lung Adenocarcinoma Transcript 1 (MALAT1) Promotes Renal Cell Carcinoma Progression via Sponging miRNA-429. Medical Science Monitor 24: 1794–1801. 10.12659/MSM.909450 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Cui SQ, Wang H (2015) MicroRNA-144 inhibits the proliferation, apoptosis, invasion, and migration of osteosarcoma cell line F5M2. Tumor Biology 36: 6949–6958. 10.1007/s13277-015-3396-0 [DOI] [PubMed] [Google Scholar]
  • 8.Shi J, Zhang D, Zhong Z, Zhang W (2019) lncRNA ROR promotes the progression of renal cell carcinoma through the miR-206/VEGF axis. Molecular Medicine Reports 20(4): 3782–3792. 10.3892/mmr.2019.10636 [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
  • 9.Yue D, Qin X (2018) miR-182 regulates trastuzumab resistance by targeting MET in breast cancer cells. Cancer Gene Therapy 26: 1–10. 10.1038/s41417-018-0031-4 [DOI] [PubMed] [Google Scholar]
  • 10.Pei X, Li M, Zhan J, Yu Y, Wei X, Guan L, et al. (2015) Enhanced IMP3 Expression Activates NF-кB Pathway and Promotes Renal Cell Carcinoma Progression. PLoS ONE 10(4): e0124338. 10.1371/journal.pone.0124338 [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
  • 11.The PLOS ONE Editors (2024) Retraction: Enhanced IMP3 Expression Activates NF-кB Pathway and Promotes Renal Cell Carcinoma Progression. PLoS ONE 19(4): e0301575. 10.1371/journal.pone.0301575 [DOI] [PubMed] [Google Scholar]
  • 12.Zhou L, Zhang N, Song W, You N, Li Q, Sun W, et al. (2013) The Significance of Notch1 Compared with Notch3 in High Metastasis and Poor Overall Survival in Hepatocellular Carcinoma. PLoS ONE 8(2): e57382. 10.1371/journal.pone.0057382 [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
  • 13.The PLOS ONE Editors (2024) Retraction: The Significance of Notch1 Compared with Notch3 in High Metastasis and Poor Overall Survival in Hepatocellular Carcinoma. PLoS ONE 19(4): e0301556. 10.1371/journal.pone.0301556 [DOI] [PubMed] [Google Scholar]

Articles from PLOS ONE are provided here courtesy of PLOS

RESOURCES